OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Allergy and Clinical Immunology is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
What molecular allergy teaches us about genetics and epidemiology of allergies	51
The pathogenetic role of Th17 immune response in atopic dermatitis	34
The use of environmental exposure chambers in studies related to ocular surface effects	30
The collaborative medical practice of the ocular surface: a major role of the allergist/immunologist	29
Liver disease in primary antibody deficiencies	26
Chronic spontaneous urticaria: new evidences on the role of autoimmunity	25
Economic burden of drug-induced anaphylaxis: what can we do better?	22
Dietary strategies for the prevention of asthma in children	21
Consequences of severe asthma exacerbations	21
Anaphylaxis due to antiallergic and antiasthmatic biologics	18
Cow's milk allergy	17
Pulmonary function testing for the diagnosis of asthma in preschool children	17
Drug allergy awareness and perspectives with the implementation of the International Classification of Diseases-11	16
E-cigarettes and asthma in adolescents	16
Real-world evidence of allergen immunotherapy	15
Is immunotherapy safe for treatment of severe asthma	15
Mast cell conditions and drug allergy: when to suspect and how to manage	14
Role of pharmacogenomics in T-cell hypersensitivity drug reactions	14
New approaches in childhood asthma treatment	14
Innate and adaptive immunity in allergic airway disease	13
Atopic manifestations of inborn errors of immunity	12
Bronchiectasis and obstructive lung diseases in primary antibody deficiencies and beyond: update on management and pathomechanisms	12
Update on occupational allergy, including asthma, to soluble platinum salts	12
Editorial: Food allergy: from defense to attack	12
Editorial introductions	11

Neuroimmune signalling pathways in chronic rhinosinusitis with nasal polyps	11
The effects of the COVID-19 pandemic on the treatment of allergic eye diseases	11
Ocular involvement in allergic drug reactions	11
Editorial introductions	11
Vernal keratoconjunctivitis and keratoconus	10
Paucity of gastrointestinal plasma cells in common variable immunodeficiency	10
Biologics as treatment options for anaphylaxis	10
Transition of care in inborn errors of immunity	10
Perioperative anaphylaxis: when the allergological work-up goes negative	10
Epidemiology of the relationship between allergic bronchopulmonary aspergillosis and asthma	10
Autologous serum eye drops for ocular surface disorders	9
Editorial introductions	9
An immunologist's perspective on anti-COVID-19 vaccines	9
Drug allergy desensitization is not a unique recipe	9
Biological therapies, asthma and coronavirus disease 2019	9
Nanoparticles in allergen immunotherapy	9
Editorial introductions	9
Editorial introductions	9
Is allergen immunotherapy a model of personalized treatment in pediatric respiratory allergy?	9
Updates in diagnosis and management of paediatric mastocytosis	9
Health disparities in allergic diseases	8
Chronic rhinosinusitis with nasal polyps: eosinophils versus B lymphocytes in disease pathogenesis	8
Editorial: Advances in drug hypersensitivity reactions	8
LNIT-Local nasal immunotherapy in allergic rhinitis: revisited evidence and perspectives	8
Greater mechanistic understanding of the cutaneous pathogenesis of Stevens–Johnson syndrome/toxic epidermal necrolysis can shed light on novel therapeutic strategies: a comprehensive review	8
Optimal use of intranasal corticosteroids and intranasal saline, is there a clear answer?	8
A review of food allergy-related costs with consideration to clinical and demographic factors	8
Basophil activation test in food allergy: is it ready for real-time?	7
Atopic dermatitis endotypes: knowledge for personalized medicine	7
Evaluating the glucagon-like peptide-1 receptor in managing asthma	7
Food-labeling issues for severe food-allergic consumers	7
Updates in school-based asthma management	7
Management and treatment of perioperative hypersensitivity	7
Precision allergy molecular diagnosis applications in food allergy	6
Exposome mapping in chronic respiratory diseases: the added value of digital technology	6
Update on hereditary C1q deficiency: pathophysiology, clinical presentation, genotype and management	6
Biomarkers in the diagnosis of mast cell activation	6
Do bacterial vaccines/adjuvants prevent wheezing episodes in children?	6
Current strategies for phenotyping and managing asthma in preschool children	6
Role of the ocular surface microbiome in allergic eye diseases	6
Clinical remission in severe asthma: lights and shadows on an ambitious goal	6
The complexity in DNA methylation analysis of allergic diseases	6
Monogenic forms of common variable immunodeficiency and implications on target therapeutic approaches	6
Strengthening the case for intralymphatic immunotherapy	6
What's new in pediatric asthma and rhinitis phenotypes and endotypes?	6
Occupational causes of chronic obstructive pulmonary disease: an update	6
Editorial introductions	6
Food allergy: new therapeutic options open deeper questions	6